ID   SYWC_HUMAN              Reviewed;         471 AA.
AC   P23381; A6NGN1; A6NID3; P78535; Q502Y0; Q53XB6; Q9UDI5; Q9UDL3;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 2.
DT   10-MAY-2017, entry version 177.
DE   RecName: Full=Tryptophan--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.2;
DE   AltName: Full=Interferon-induced protein 53;
DE            Short=IFP53;
DE   AltName: Full=Tryptophanyl-tRNA synthetase;
DE            Short=TrpRS;
DE            Short=hWRS;
DE   Contains:
DE     RecName: Full=T1-TrpRS;
DE   Contains:
DE     RecName: Full=T2-TrpRS;
GN   Name=WARS; Synonyms=IFI53, WRS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1761529;
RA   Rubin B.Y., Anderson S.L., Xing L., Powell R.J., Tate W.P.;
RT   "Interferon induces tryptophanyl-tRNA synthetase expression in human
RT   fibroblasts.";
RL   J. Biol. Chem. 266:24245-24248(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1763065; DOI=10.1073/pnas.88.24.11520;
RA   Fleckner J., Rasmussen H.H., Justesen J.;
RT   "Human interferon gamma potently induces the synthesis of a 55-kDa
RT   protein (gamma 2) highly homologous to rabbit peptide chain release
RT   factor and bovine tryptophanyl-tRNA synthetase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:11520-11524(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1765274; DOI=10.1016/0378-1119(91)90624-K;
RA   Frolova L.Y., Sudomoina M.A., Grigorieva A.Y., Zinovieva O.L.,
RA   Kisselev L.L.;
RT   "Cloning and nucleotide sequence of the structural gene encoding for
RT   human tryptophanyl-tRNA synthetase.";
RL   Gene 109:291-296(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1537332;
RA   Buwitt U., Flohr T., Boettger E.C.;
RT   "Molecular cloning and characterization of an interferon induced human
RT   cDNA with sequence homology to a mammalian peptide chain release
RT   factor.";
RL   EMBO J. 11:489-496(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Blood, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-13.
RX   PubMed=8724762;
RA   Sokolova I.V., Narovlianskii A.N., Amchenkova A.M., Turpaev K.T.;
RT   "Alternative splicing of 5'-terminal exons of the human tryptophanyl-
RT   tRNA synthetase gene.";
RL   Mol. Biol. (Mosk.) 30:319-329(1996).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-141 AND 182-471.
RC   TISSUE=Sperm;
RX   PubMed=7685728; DOI=10.1016/0378-1119(93)90568-N;
RA   Frolova L.Y., Grigorieva A.Y., Sudomoina M.A., Kisselev L.L.;
RT   "The human gene encoding tryptophanyl-tRNA synthetase: interferon-
RT   response elements and exon-intron organization.";
RL   Gene 128:237-245(1993).
RN   [12]
RP   PROTEIN SEQUENCE OF 2-19; 142-162; 205-220; 278-298; 350-366 AND
RP   433-448, AND INDUCTION.
RC   TISSUE=Keratinocyte;
RX   PubMed=8496617; DOI=10.1111/1523-1747.ep12476463;
RA   Reano A., Richard M.H., Denoroy L., Viac J., Benedetto J.P.,
RA   Schmitt D.;
RT   "Gamma interferon potently induces tryptophanyl-tRNA synthetase
RT   expression in human keratinocytes.";
RL   J. Invest. Dermatol. 100:775-779(1993).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-24; 97-106; 433-448 AND 465-471, CLEAVAGE OF
RP   INITIATOR METHIONINE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [14]
RP   PROTEIN SEQUENCE OF 71-75 AND 91-98, PROTEOLYTIC CLEAVAGE, AND
RP   FUNCTION.
RX   PubMed=11773626; DOI=10.1073/pnas.012602099;
RA   Wakasugi K., Slike B.M., Hood J., Otani A., Ewalt K.L.,
RA   Friedlander M., Cheresh D.A., Schimmel P.;
RT   "A human aminoacyl-tRNA synthetase as a regulator of angiogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:173-177(2002).
RN   [15]
RP   PROTEIN SEQUENCE OF 265-276; 278-296; 299-317 AND 350-365.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [16]
RP   FUNCTION.
RX   PubMed=1373391; DOI=10.1016/0014-5793(92)80187-L;
RA   Bange F.-C., Flohr T., Buwitt U., Boettger E.C.;
RT   "An interferon-induced protein with release factor activity is a
RT   tryptophanyl-tRNA synthetase.";
RL   FEBS Lett. 300:162-166(1992).
RN   [17]
RP   ALTERNATIVE SPLICING.
RX   PubMed=7814400; DOI=10.1074/jbc.270.1.397;
RA   Tolstrup A.B., Bejder A., Fleckner J., Justesen J.;
RT   "Transcriptional regulation of the interferon-gamma-inducible
RT   tryptophanyl-tRNA synthetase includes alternative splicing.";
RL   J. Biol. Chem. 270:397-403(1995).
RN   [18]
RP   FUNCTION.
RX   PubMed=11773625; DOI=10.1073/pnas.012601899;
RA   Otani A., Slike B.M., Dorrell M.I., Hood J., Kinder K., Ewalt K.L.,
RA   Cheresh D., Schimmel P., Friedlander M.;
RT   "A fragment of human TrpRS as a potent antagonist of ocular
RT   angiogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:178-183(2002).
RN   [19]
RP   FUNCTION.
RX   PubMed=14630953; DOI=10.1073/pnas.2436330100;
RA   Tzima E., Reader J.S., Irani-Tehrani M., Ewalt K.L., Schwartz M.A.,
RA   Schimmel P.;
RT   "Biologically active fragment of a human tRNA synthetase inhibits
RT   fluid shear stress-activated responses of endothelial cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:14903-14907(2003).
RN   [20]
RP   INTERACTION WITH GAPDH.
RX   PubMed=15628863; DOI=10.1021/bi048313k;
RA   Wakasugi K., Nakano T., Morishima I.;
RT   "Oxidative stress-responsive intracellular regulation specific for the
RT   angiostatic form of human tryptophanyl-tRNA synthetase.";
RL   Biochemistry 44:225-232(2005).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-351, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 1-466.
RX   PubMed=14671330; DOI=10.1073/pnas.2136794100;
RA   Yang X.-L., Otero F.J., Skene R.J., McRee D.E., Schimmel P.,
RA   Ribas de Pouplana L.;
RT   "Crystal structures that suggest late development of genetic code
RT   components for differentiating aromatic side chains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15376-15380(2003).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 94-471.
RX   PubMed=14660560; DOI=10.1074/jbc.M311284200;
RA   Yu Y., Liu Y., Shen N., Xu X., Xu F., Jia J., Jin Y., Arnold E.,
RA   Ding J.;
RT   "Crystal structure of human tryptophanyl-tRNA synthetase catalytic
RT   fragment: insights into substrate recognition, tRNA binding, and
RT   angiogenesis activity.";
RL   J. Biol. Chem. 279:8378-8388(2004).
RN   [30]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-455.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Isoform 1, isoform 2 and T1-TrpRS have aminoacylation
CC       activity while T2-TrpRS lacks it. Isoform 2, T1-TrpRS and T2-TrpRS
CC       possess angiostatic activity whereas isoform 1 lacks it. T2-TrpRS
CC       inhibits fluid shear stress-activated responses of endothelial
CC       cells. Regulates ERK, Akt, and eNOS activation pathways that are
CC       associated with angiogenesis, cytoskeletal reorganization and
CC       shear stress-responsive gene expression.
CC       {ECO:0000269|PubMed:11773625, ECO:0000269|PubMed:11773626,
CC       ECO:0000269|PubMed:1373391, ECO:0000269|PubMed:14630953}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-tryptophan + tRNA(Trp) = AMP +
CC       diphosphate + L-tryptophyl-tRNA(Trp).
CC   -!- SUBUNIT: Homodimer. Isoform 1 and isoform 2 interact with an
CC       oxidized form of GAPDH. GAPDH stimulates the aminoacylation
CC       activity of isoform 2.
CC   -!- INTERACTION:
CC       P54274:TERF1; NbExp=2; IntAct=EBI-721244, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P23381-1; Sequence=Displayed;
CC       Name=2; Synonyms=mini TrpRS;
CC         IsoId=P23381-2; Sequence=VSP_038221;
CC   -!- INDUCTION: By IFNG/IFN-gamma. {ECO:0000269|PubMed:8496617}.
CC   -!- PTM: Proteolytic cleavage generates 2 forms; T1-TrpRS and T2-
CC       TrpRS. {ECO:0000269|PubMed:11773626}.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M77804; AAA67324.1; -; mRNA.
DR   EMBL; X59892; CAA42545.1; -; mRNA.
DR   EMBL; M61715; AAA61298.1; -; mRNA.
DR   EMBL; X62570; CAA44450.1; -; mRNA.
DR   EMBL; BX248006; CAD62335.1; -; mRNA.
DR   EMBL; AK056100; BAG51626.1; -; mRNA.
DR   EMBL; AK291141; BAF83830.1; -; mRNA.
DR   EMBL; AL157871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81700.1; -; Genomic_DNA.
DR   EMBL; BC017489; AAH17489.1; -; mRNA.
DR   EMBL; BC095453; AAH95453.1; -; mRNA.
DR   EMBL; S82905; AAB39381.1; -; Genomic_DNA.
DR   EMBL; X67920; CAB94198.1; -; Genomic_DNA.
DR   EMBL; X67921; CAB94198.1; JOINED; Genomic_DNA.
DR   EMBL; X67922; CAB94198.1; JOINED; Genomic_DNA.
DR   EMBL; X67923; CAB94199.1; -; Genomic_DNA.
DR   EMBL; X67924; CAB94199.1; JOINED; Genomic_DNA.
DR   EMBL; X67925; CAB94199.1; JOINED; Genomic_DNA.
DR   EMBL; X67926; CAB94199.1; JOINED; Genomic_DNA.
DR   EMBL; X67927; CAB94199.1; JOINED; Genomic_DNA.
DR   EMBL; X67928; CAB94199.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS9960.1; -. [P23381-1]
DR   CCDS; CCDS9961.1; -. [P23381-2]
DR   PIR; A41633; A41706.
DR   RefSeq; NP_004175.2; NM_004184.3. [P23381-1]
DR   RefSeq; NP_776049.1; NM_173701.1. [P23381-1]
DR   RefSeq; NP_998810.1; NM_213645.1. [P23381-2]
DR   RefSeq; NP_998811.1; NM_213646.1. [P23381-2]
DR   RefSeq; XP_005268101.1; XM_005268044.3. [P23381-1]
DR   RefSeq; XP_006720312.1; XM_006720249.3. [P23381-1]
DR   RefSeq; XP_011535435.1; XM_011537133.2. [P23381-1]
DR   RefSeq; XP_011535437.1; XM_011537135.2. [P23381-1]
DR   RefSeq; XP_011535438.1; XM_011537136.2. [P23381-2]
DR   RefSeq; XP_016877116.1; XM_017021627.1. [P23381-1]
DR   RefSeq; XP_016877117.1; XM_017021628.1. [P23381-1]
DR   RefSeq; XP_016877118.1; XM_017021629.1. [P23381-1]
DR   UniGene; Hs.497599; -.
DR   PDB; 1O5T; X-ray; 2.50 A; A=94-471.
DR   PDB; 1R6T; X-ray; 2.10 A; A/B=1-466.
DR   PDB; 1R6U; X-ray; 2.00 A; A/B=48-471.
DR   PDB; 1ULH; X-ray; 2.31 A; A/B=82-471.
DR   PDB; 2AKE; X-ray; 3.10 A; A=94-471.
DR   PDB; 2AZX; X-ray; 2.80 A; A/B=1-471.
DR   PDB; 2DR2; X-ray; 3.00 A; A=94-471.
DR   PDB; 2QUH; X-ray; 2.40 A; A/B=1-471.
DR   PDB; 2QUI; X-ray; 2.40 A; A/B=1-471.
DR   PDB; 2QUJ; X-ray; 2.42 A; A/B=1-471.
DR   PDB; 2QUK; X-ray; 2.80 A; A=1-471.
DR   PDBsum; 1O5T; -.
DR   PDBsum; 1R6T; -.
DR   PDBsum; 1R6U; -.
DR   PDBsum; 1ULH; -.
DR   PDBsum; 2AKE; -.
DR   PDBsum; 2AZX; -.
DR   PDBsum; 2DR2; -.
DR   PDBsum; 2QUH; -.
DR   PDBsum; 2QUI; -.
DR   PDBsum; 2QUJ; -.
DR   PDBsum; 2QUK; -.
DR   ProteinModelPortal; P23381; -.
DR   SMR; P23381; -.
DR   BioGrid; 113292; 60.
DR   DIP; DIP-29493N; -.
DR   IntAct; P23381; 8.
DR   MINT; MINT-1408962; -.
DR   STRING; 9606.ENSP00000347495; -.
DR   DrugBank; DB00150; L-Tryptophan.
DR   DrugBank; DB04537; L-Tryptophanamide.
DR   DrugBank; DB01831; Tryptophanyl-5'amp.
DR   MoonProt; P23381; -.
DR   iPTMnet; P23381; -.
DR   PhosphoSitePlus; P23381; -.
DR   SwissPalm; P23381; -.
DR   BioMuta; WARS; -.
DR   DMDM; 135191; -.
DR   OGP; P23381; -.
DR   EPD; P23381; -.
DR   MaxQB; P23381; -.
DR   PaxDb; P23381; -.
DR   PeptideAtlas; P23381; -.
DR   PRIDE; P23381; -.
DR   Ensembl; ENST00000344102; ENSP00000339485; ENSG00000140105. [P23381-2]
DR   Ensembl; ENST00000355338; ENSP00000347495; ENSG00000140105. [P23381-1]
DR   Ensembl; ENST00000358655; ENSP00000351481; ENSG00000140105. [P23381-2]
DR   Ensembl; ENST00000392882; ENSP00000376620; ENSG00000140105. [P23381-1]
DR   Ensembl; ENST00000556645; ENSP00000451887; ENSG00000140105. [P23381-2]
DR   Ensembl; ENST00000557135; ENSP00000451460; ENSG00000140105. [P23381-1]
DR   GeneID; 7453; -.
DR   KEGG; hsa:7453; -.
DR   UCSC; uc001yhg.3; human. [P23381-1]
DR   CTD; 7453; -.
DR   DisGeNET; 7453; -.
DR   GeneCards; WARS; -.
DR   HGNC; HGNC:12729; WARS.
DR   HPA; HPA005573; -.
DR   HPA; HPA018944; -.
DR   MIM; 191050; gene.
DR   neXtProt; NX_P23381; -.
DR   OpenTargets; ENSG00000140105; -.
DR   PharmGKB; PA37340; -.
DR   eggNOG; KOG2145; Eukaryota.
DR   eggNOG; COG0180; LUCA.
DR   GeneTree; ENSGT00390000000666; -.
DR   HOVERGEN; HBG002325; -.
DR   InParanoid; P23381; -.
DR   KO; K01867; -.
DR   OMA; FFFSHRD; -.
DR   OrthoDB; EOG091G09U9; -.
DR   PhylomeDB; P23381; -.
DR   TreeFam; TF105669; -.
DR   BRENDA; 6.1.1.2; 2681.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; WARS; human.
DR   EvolutionaryTrace; P23381; -.
DR   GeneWiki; WARS_(gene); -.
DR   GenomeRNAi; 7453; -.
DR   PRO; PR:P23381; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000140105; -.
DR   CleanEx; HS_WARS; -.
DR   ExpressionAtlas; P23381; baseline and differential.
DR   Genevisible; P23381; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019210; F:kinase inhibitor activity; IDA:CAFA.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:0019901; F:protein kinase binding; IPI:CAFA.
DR   GO; GO:0004830; F:tryptophan-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:CAFA.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IDA:CAFA.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:CAFA.
DR   GO; GO:0031334; P:positive regulation of protein complex assembly; IMP:CAFA.
DR   GO; GO:0045765; P:regulation of angiogenesis; IDA:UniProtKB.
DR   GO; GO:0010835; P:regulation of protein ADP-ribosylation; IDA:CAFA.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   GO; GO:0006436; P:tryptophanyl-tRNA aminoacylation; IBA:GO_Central.
DR   CDD; cd00806; TrpRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002305; aa-tRNA-synth_Ic.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009068; S15_NS1_RNA-bd.
DR   InterPro; IPR002306; Trp-tRNA-ligase.
DR   InterPro; IPR000738; WHEP-TRS_dom.
DR   Pfam; PF00579; tRNA-synt_1b; 1.
DR   Pfam; PF00458; WHEP-TRS; 1.
DR   PRINTS; PR01039; TRNASYNTHTRP.
DR   SMART; SM00991; WHEP-TRS; 1.
DR   SUPFAM; SSF47060; SSF47060; 1.
DR   TIGRFAMs; TIGR00233; trpS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
DR   PROSITE; PS00762; WHEP_TRS_1; 1.
DR   PROSITE; PS51185; WHEP_TRS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Aminoacyl-tRNA synthetase;
KW   Angiogenesis; ATP-binding; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Ligase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein biosynthesis; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|PubMed:8496617,
FT                                ECO:0000269|Ref.13}.
FT   CHAIN         2    471       Tryptophan--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000136738.
FT   CHAIN        71    471       T1-TrpRS.
FT                                /FTId=PRO_0000386461.
FT   CHAIN        94    471       T2-TrpRS.
FT                                /FTId=PRO_0000386462.
FT   DOMAIN        8     64       WHEP-TRS. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00531}.
FT   MOTIF       164    173       "HIGH" region.
FT   MOTIF       349    353       "KMSKS" region.
FT   MOD_RES     154    154       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32921}.
FT   MOD_RES     351    351       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     41       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038221.
FT   VARIANT      54     54       A -> S (in dbSNP:rs2234521).
FT                                /FTId=VAR_052406.
FT   VARIANT     455    455       E -> D (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036466.
FT   CONFLICT    213    214       SY -> GD (in Ref. 3; AAA61298).
FT                                {ECO:0000305}.
FT   CONFLICT    310    310       A -> V (in Ref. 9; AAH95453).
FT                                {ECO:0000305}.
FT   CONFLICT    424    424       A -> R (in Ref. 4; CAA44450).
FT                                {ECO:0000305}.
FT   CONFLICT    439    439       Q -> L (in Ref. 9; AAH95453).
FT                                {ECO:0000305}.
FT   HELIX         8     28       {ECO:0000244|PDB:1R6T}.
FT   HELIX        33     53       {ECO:0000244|PDB:1R6T}.
FT   STRAND       54     56       {ECO:0000244|PDB:1R6T}.
FT   STRAND       84     86       {ECO:0000244|PDB:1R6U}.
FT   STRAND       89     91       {ECO:0000244|PDB:1R6U}.
FT   TURN        100    102       {ECO:0000244|PDB:1R6U}.
FT   HELIX       103    106       {ECO:0000244|PDB:1R6U}.
FT   HELIX       114    124       {ECO:0000244|PDB:1R6U}.
FT   HELIX       130    133       {ECO:0000244|PDB:1R6U}.
FT   STRAND      136    142       {ECO:0000244|PDB:1R6U}.
FT   HELIX       143    150       {ECO:0000244|PDB:1R6U}.
FT   TURN        151    153       {ECO:0000244|PDB:1R6U}.
FT   STRAND      156    162       {ECO:0000244|PDB:1R6U}.
FT   HELIX       171    187       {ECO:0000244|PDB:1R6U}.
FT   STRAND      191    195       {ECO:0000244|PDB:1R6U}.
FT   HELIX       197    203       {ECO:0000244|PDB:1R6U}.
FT   HELIX       208    223       {ECO:0000244|PDB:1R6U}.
FT   TURN        224    226       {ECO:0000244|PDB:1R6U}.
FT   HELIX       229    231       {ECO:0000244|PDB:1R6U}.
FT   STRAND      232    236       {ECO:0000244|PDB:1R6U}.
FT   HELIX       237    240       {ECO:0000244|PDB:1R6U}.
FT   HELIX       241    243       {ECO:0000244|PDB:1R6U}.
FT   HELIX       247    256       {ECO:0000244|PDB:1R6U}.
FT   HELIX       260    267       {ECO:0000244|PDB:1R6U}.
FT   STRAND      271    274       {ECO:0000244|PDB:1ULH}.
FT   HELIX       275    285       {ECO:0000244|PDB:1R6U}.
FT   HELIX       286    288       {ECO:0000244|PDB:1R6U}.
FT   HELIX       290    292       {ECO:0000244|PDB:1R6U}.
FT   HELIX       294    297       {ECO:0000244|PDB:1R6U}.
FT   STRAND      304    310       {ECO:0000244|PDB:1R6U}.
FT   HELIX       311    313       {ECO:0000244|PDB:1R6U}.
FT   HELIX       314    323       {ECO:0000244|PDB:1R6U}.
FT   HELIX       324    327       {ECO:0000244|PDB:1R6U}.
FT   STRAND      333    337       {ECO:0000244|PDB:1R6U}.
FT   STRAND      345    349       {ECO:0000244|PDB:1R6U}.
FT   STRAND      354    357       {ECO:0000244|PDB:1R6U}.
FT   STRAND      360    362       {ECO:0000244|PDB:2AZX}.
FT   HELIX       365    374       {ECO:0000244|PDB:1R6U}.
FT   HELIX       384    390       {ECO:0000244|PDB:1R6U}.
FT   TURN        394    396       {ECO:0000244|PDB:1R6U}.
FT   HELIX       398    406       {ECO:0000244|PDB:1R6U}.
FT   HELIX       410    422       {ECO:0000244|PDB:1R6U}.
FT   STRAND      423    425       {ECO:0000244|PDB:1R6U}.
FT   HELIX       430    450       {ECO:0000244|PDB:1R6U}.
FT   HELIX       454    460       {ECO:0000244|PDB:1R6U}.
SQ   SEQUENCE   471 AA;  53165 MW;  E96344449053A0D0 CRC64;
     MPNSEPASLL ELFNSIATQG ELVRSLKAGN ASKDEIDSAV KMLVSLKMSY KAAAGEDYKA
     DCPPGNPAPT SNHGPDATEA EEDFVDPWTV QTSSAKGIDY DKLIVRFGSS KIDKELINRI
     ERATGQRPHH FLRRGIFFSH RDMNQVLDAY ENKKPFYLYT GRGPSSEAMH VGHLIPFIFT
     KWLQDVFNVP LVIQMTDDEK YLWKDLTLDQ AYSYAVENAK DIIACGFDIN KTFIFSDLDY
     MGMSSGFYKN VVKIQKHVTF NQVKGIFGFT DSDCIGKISF PAIQAAPSFS NSFPQIFRDR
     TDIQCLIPCA IDQDPYFRMT RDVAPRIGYP KPALLHSTFF PALQGAQTKM SASDPNSSIF
     LTDTAKQIKT KVNKHAFSGG RDTIEEHRQF GGNCDVDVSF MYLTFFLEDD DKLEQIRKDY
     TSGAMLTGEL KKALIEVLQP LIAEHQARRK EVTDEIVKEF MTPRKLSFDF Q
//
